US Chronic Disease Management Growth Opportunities

US Chronic Disease Management Growth Opportunities

Future Growth Potential Enhanced by the Pandemic and Growth Opportunities in Chronic Disease Management

RELEASE DATE
06-Oct-2021
REGION
North America
Research Code: PBD9-01-00-00-00
SKU: HC03453-NA-MT_25801
$4,950.00
In stock
SKU
HC03453-NA-MT_25801
$4,950.00
DownloadLink

Pay by invoice

ENQUIRE NOW

Description

The prevalence of chronic diseases has continued to rise, and the expenses of managing them or treating the complications arising from poor management cost the US healthcare system hundreds of billions of dollars each year. Clearly, physicians alone cannot control this rising challenge, and to ensure behavioral change, several tools and approaches are necessary to support the care team, such as remote patient monitoring (RPM), digital therapeutics, and the right nudges for motivation at the right time.

Several market participants are now offering such solutions to providers, payers, and employers (and in some cases, directly to the patients) to help patients suffering from cardiovascular, diabetes, and chronic obstructive pulmonary disorder (COPD) manage their conditions better.

The market participants are categorized on the basis of the kind of solutions they offer—RPM and digital therapeutics solutions, on the tech-only solution side, and valued-added RPM, coaching platforms and digital care, on the ‘tech + human’ intervention solutions side. While the industry continues to debate the better approach, the segments will see significant growth, as all of these approaches are gunning to help chronically ill patients stay healthier longer, reduce frequency and cost of hospital admissions, or disease-related complications in the long run. These tech-enabled solutions also address one of the major challenges of the healthcare industry—shortage of resources. The solutions complement the services of doctors and healthcare professionals and empower a larger portion of the increasing patient population with tech-enabled tools.

This study covers cardiovascular conditions, diabetes, and COPD, the major diseases afflicting the US population and responsible for a sizeable portion of the $3 trillion US healthcare cost. This study defines, compares, and contrasts the different models of chronic disease management care models, such as RPM, digital therapeutics, coaching platforms, value-added RPM, and digital care in terms of their strengths and weaknesses, revenues and growth rates, and potential to serve various customer segments. It identifies the major participants in each segment and also outlines the current focus of all segments within each of the three disease areas’ patient pathways. Finally, it covers evolving business models, and select profiles of some companies, while also highlighting the future of this market in terms of reimbursements and market growth, ultimately helping uncover the major growth opportunities in this sector.

Key Issues Addressed

  • What are the different segments for solution vendors offering chronic disease management solutions, and how do they differ from one another?
  • What are the current (and future) target customer segments for each of these vendor segments?
  • Which are the unique, leading participants in this sector, and what are the evolving business models in this space?
  • How and when does the market adoption shift from just management to broader adoption of management-and-prevention solutions, in the light of current trends?
  • How are current pharmaceutical and medtech incumbents viewing the rise of such solutions, and how are they playing a role in this space?

Author: Siddharth Shah

RESEARCH: INFOGRAPHIC

This infographic presents a brief overview of the research, and highlights the key topics discussed in it.
Click image to view it in full size

Table of Contents

Why Is It Increasingly Difficult to Grow?

The Strategic Imperative 8™

Impact of the Top Three Strategic Imperatives on the Global Chronic Disease Management Industry

Growth Opportunities Fuel the Growth Pipeline Engine™

Top 10 Causes of DALYs and Mortality, 2000–2019

Top 10 Causes of Mortality by GNI Per Capita, 2019

Prevalence of the Top 3 Chronic Conditions

Obesity Driving Incidence of Chronic Conditions Worldwide

Evolution of Approaches to Manage Chronic Condition Patients

Analysis of Prevalent Disease Management Approaches

The ‘Digital Care’ Model for Chronic Disease Management

Impact of the COVID-19 Pandemic on Virtual Care

Chronic Disease Management Snapshot, US

Chronic Disease Management Growth Opportunity Snapshot

Scope of Analysis

Segmentation

Definitions

Key Competitors

Key Growth Metrics

Growth Drivers

Growth Restraints

Forecast Assumptions

Revenue Forecast

Revenue Forecast by Care Model

Revenue Forecast Analysis

Competitive Environment

Revenue Share

Revenue Share Analysis

Key Growth Metrics, RPM

Revenue Forecast, RPM

Forecast Analysis, RPM

Key Growth Metrics, Digital Care Providers

Revenue Forecast, Digital Care Providers

Forecast Analysis, Digital Care Providers

Key Growth Metrics, Coaching Platforms

Revenue Forecast, Coaching Platforms

Forecast Analysis, Coaching Platforms

Key Growth Metrics, Value-added RPM

Revenue Forecast, Value-added RPM

Forecast Analysis, Value-added RPM

Key Growth Metrics, Digital Therapeutics

Revenue Forecast, Digital Therapeutics

Forecast Analysis, Digital Therapeutics

Mapping Vendor Focus Areas Across the Cardiovascular Patient Pathway

Managing Cardiovascular Conditions & Risk Stratification

Unique Cardiovascular Disease Management Market Participants

Future Roadmap

Mapping Vendor Focus Areas Across Diabetes Patient Pathway

Managing Diabetics—Risk Stratification

Unique Diabetes Management Market Participants

Future Roadmap

Mapping Vendor Focus Areas Across COPD Patient Pathway

Managing COPD—Risk Stratification

Unique COPD Management Market Participants

Future Roadmap

Approaches to Maximize Reach and Revenue

RPM Chronic Disease Management Success Story—Validic

End-to-End Integration Approach—Raziel Health

Addressing a Variety of Customer Needs—Marketplaces

Innovative Patient Engagement Models with a Business Model Impact

Growth of Disease Management and Prevention Programs

Timeline for Disease Management Programs’ Adoption

Timeline for Disease Management Programs’ Adoption (continued)

RPM Segment Poised to Benefit the Most from Future Chronic Condition Management Programs

Potential Reach of Chronic Disease Management Participants

Changing Epidemiology & Prevalent Growth Rates

Hospital at Home—The Impetus to Bolster the Reach of Chronic Disease Management Programs

Technology Advancement Simplifying Vitals Gathering to Help Address Compliance Barriers to Chronic Disease Management

Disease Management Growth Opportunities for Incumbent Medtech and Pharma Participants

Growth Opportunity 1—Addressal of Risk Factors, Social Determinants, and Complications Management for Improved Outcomes

Growth Opportunity 1—Addressal of Risk Factors, Social Determinants, and Complications Management for Improved Outcomes (continued)

Growth Opportunity 2—Partnerships with Hospital-at-Home Vendors for Management of Acute Events

Growth Opportunity 2—Partnership with Hospital-at-Home Vendors for Management of Acute Events (continued)

Growth Opportunity 3—Comorbidity Treatments for Holistic Wellbeing

Growth Opportunity 3—Comorbidity Treatments for Holistic Wellbeing (continued)

Growth Opportunity 4—Pharmaceutical/Medtech OEM Partnerships with Disease Management Vendors for Adherence and Data Access

Growth Opportunity 4—Pharmaceutical/Medtech OEM Partnerships with Disease Management Vendors for Adherence and Data Access (continued)

Growth Opportunity 5—New Features and Business Models for Enhanced Revenue Streams

Growth Opportunity 5—New Features and Business Models for Enhanced Revenue Streams (continued)

Growth Opportunity 5—New Features and Business Models for Enhanced Revenue Streams (continued)

Your Next Steps

Why Frost, Why Now?

List of Exhibits

List of Exhibits (continued)

List of Exhibits (continued)

Legal Disclaimer

Related Research
The prevalence of chronic diseases has continued to rise, and the expenses of managing them or treating the complications arising from poor management cost the US healthcare system hundreds of billions of dollars each year. Clearly, physicians alone cannot control this rising challenge, and to ensure behavioral change, several tools and approaches are necessary to support the care team, such as remote patient monitoring (RPM), digital therapeutics, and the right nudges for motivation at the right time. Several market participants are now offering such solutions to providers, payers, and employers (and in some cases, directly to the patients) to help patients suffering from cardiovascular, diabetes, and chronic obstructive pulmonary disorder (COPD) manage their conditions better. The market participants are categorized on the basis of the kind of solutions they offer—RPM and digital therapeutics solutions, on the tech-only solution side, and valued-added RPM, coaching platforms and digital care, on the ‘tech + human’ intervention solutions side. While the industry continues to debate the better approach, the segments will see significant growth, as all of these approaches are gunning to help chronically ill patients stay healthier longer, reduce frequency and cost of hospital admissions, or disease-related complications in the long run. These tech-enabled solutions also address one of the major challenges of the healthcare industry—shortage of resources. The solutions complement the services of doctors and healthcare professionals and empower a larger portion of the increasing patient population with tech-enabled tools. This study covers cardiovascular conditions, diabetes, and COPD, the major diseases afflicting the US population and responsible for a sizeable portion of the $3 trillion US healthcare cost. This study defines, compares, and contrasts the different models of chronic disease management care models, such as RPM, digital therapeutics, coaching platforms, value-added RPM, and digital care in terms of their strengths and weaknesses, revenues and growth rates, and potential to serve various customer segments. It identifies the major participants in each segment and also outlines the current focus of all segments within each of the three disease areas’ patient pathways. Finally, it covers evolving business models, and select profiles of some companies, while also highlighting the future of this market in terms of reimbursements and market growth, ultimately helping uncover the major growth opportunities in this sector.--BEGIN PROMO--

Key Issues Addressed

  • What are the different segments for solution vendors offering chronic disease management solutions, and how do they differ from one another
  • What are the current (and future) target customer segments for each of these vendor segments
  • Which are the unique, leading participants in this sector, and what are the evolving business models in this space
  • How and when does the market adoption shift from just management to broader adoption of management-and-prevention solutions, in the light of current trends
  • How are current pharmaceutical and medtech incumbents viewing the rise of such solutions, and how are they playing a role in this space

Author: Siddharth Shah

More Information
No Index No
Podcast No
Author Siddharth Shah
Industries Healthcare
WIP Number PBD9-01-00-00-00
Is Prebook No
GPS Codes 9564-B1,9600-B1,9612-B1,9A47-B1,9A4B-B1